AbbVie
ABBV
#25
Rank
โ‚น35.769 T
Marketcap
โ‚น20,239
Share price
0.98%
Change (1 day)
39.48%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น333.98 Billion a decrease over its 2023 earnings that were of โ‚น561.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-56.9%
2024 โ‚น333.98 B-40.54%
2023 โ‚น561.73 B-53.62%
2022 โ‚น1.211 T3.76%
2021 โ‚น1.167 T282.25%
2020 โ‚น305.40 B-59.67%
2019 โ‚น757.31 B62.13%
2018 โ‚น467.09 B-32.74%
2017 โ‚น694.48 B-1.99%
2016 โ‚น708.59 B18.65%
2015 โ‚น597.23 B180.5%
2014 โ‚น212.92 B-55.57%
2013 โ‚น479.22 B-6.86%
2012 โ‚น514.54 B56.05%
2011 โ‚น329.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.065 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.98 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.022 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น740.95 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น888.53 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.12 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น837.92 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น1.176 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น52.41 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA